focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,132.00
Bid: 12,130.00
Ask: 12,132.00
Change: -34.00 (-0.28%)
Spread: 2.00 (0.016%)
Open: 12,186.00
High: 12,198.00
Low: 12,114.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Stricter lockdown restrictions probably on the way, says UK PM Johnson

Sun, 03rd Jan 2021 10:28

* COVID-19 cases at record levels in UK, and rising

* Children should attend school where permitted - PM

* Vaccine delivery set to accelerate on Monday
(Adds latest data)

By William James

LONDON, Jan 3 (Reuters) - British Prime Minister Boris
Johnson said on Sunday tougher lockdown restrictions were
probably on the way as COVID-19 cases keep rising, but that
schools were safe and children should continue to attend where
permitted.

COVID-19 cases in Britain are at record levels and the
increase in numbers is fuelled by a new and more transmissible
variant of the virus. The government has cancelled the planned
reopening of schools in and around London but teaching unions
want wider closures.

Much of England is already living under the toughest level
of restriction under a four-tier system of regional regulations
designed to stop the spread of the virus and protect the
national healthcare system.

But, asked in a BBC interview about concerns that the system
may not be enough to bring the virus under control, Johnson said
restrictions "alas, might be about to get tougher".

"There are obviously a range of tougher measures that we
would have to consider ... I'm not going to speculate now about
what they would be," he said.

Johnson sets policy for England, with rules in Scotland,
Northern Ireland and Wales set by their devolved authorities.

Scottish leader Nicola Sturgeon said her cabinet would meet
on Monday to discuss possible further steps to limit the spread
of the virus, and ordered Scotland's parliament to be recalled.

Britain recorded 54,990 new cases of the virus on Sunday and
has registered more than 75,000 deaths from the pandemic.

The government's response has been heavily criticised. But
the rollout of vaccines is set to accelerate on Monday with the
first 530,000 doses of the newly approved Oxford/AstraZeneca
vaccines ready to be administered, Johnson said.

He hoped "tens of millions" would be treated over the next
three months.

Millions of pupils are due to return from their Christmas
holidays on Monday, and Johnson advised parents to send their
children to school in areas where rules allow it.

"There is no doubt in my mind that schools are safe, and
that education is a priority," he said.

Some local authorities and unions have warned against
reopening schools and have threatened to act against government
advice. Others say closures also have a big negative impact on
students.

"We must renew and maintain the consensus that children’s
time out of school should be kept to the absolute minimum,"
Amanda Spielman, chief schools inspector, wrote in the Sunday
Telegraph.
(Reporting by William James; Editing by Alison Williams,
William Maclean and Timothy Heritage)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.